Computational analysis compares molecular measurements from individual cells to group cells with related profiles. These groups help define cell types and distinguish cellular states within the sampled biological system. The resulting relationships provide a structured view of how different cell populations coexist, rather than treating the specimen as a single molecular unit.
Spatial information links identified molecular states or cell types to their physical locations in a tissue. This connection allows investigators to examine tissue organization and relationships among neighboring or differently positioned cell populations. In medicine, placing cellular findings within tissue structure can make disease-associated changes more interpretable than molecular descriptions alone.
Cellular heterogeneity shows that a tissue or tumor can contain multiple populations with different molecular states. Single-cell mapping can distinguish these populations, including disease-associated cells and varied tumor cell states. Such distinctions help investigators examine disease mechanisms and evaluate how different cellular groups may relate to responses to treatment.
A typical workflow begins with single-cell measurements, such as gene-expression profiling, followed by computational analysis. The analysis groups related cells, defines cellular states or cell types, and incorporates spatial information when it is available. Investigators can then interpret the resulting map in relation to tissue organization, disease features, or treatment responses.
Researchers may apply single-cell mapping when tissue-level measurements do not adequately resolve distinct cell populations or states. The approach is useful for investigating disease-associated populations, tumor heterogeneity, and treatment responses. It can also support studies that seek clearer explanations of disease mechanisms, potential biomarkers, or more precise therapeutic development.
The resulting maps can clarify how cellular populations and states are arranged within diseased or healthy tissue. These insights may support biomarker discovery by identifying disease-relevant cellular features, while also informing more precise diagnosis and therapeutic development. In cancer research, mapping tumor heterogeneity can provide context for interpreting differences among tumor-associated cell populations.